QDIS Blog

Amgen is the latest to get into the merger mania and has offerd $420 million for Ilypsa.

Amgen to pay $420 mln cash for Ilypsa - MarketWatch

Amgen wants access to Ilypsa’a ILY101 a drug for the treatment of hyperphosphatemia in chronic kidney disease (CKD) patients on hemodialysis.

Here is the press release.

Technorati Tags: Amgen, hyperphosphatemia, ILY101, Ilypsa

Email Ed Vawter

Bookmark it with: | del.icio.us | Digg it | Furl | Simpy | Spurl | My Yahoo! |

Amgen has another merger in process, now with Alantos for $300 million.

RED HERRING | Amgen to Acquire Alantos:

Now they also are purchasing Ilpysa which I posted about recently. Altantos has a phase II drug for diabetes a somewhat crowded market. I personally think they may have overpiad for what they get.

I find it interesting that now even the biotechs are getting into the acquisition mania. It wouldn’t surprise me if Genetech starts on a buying binge just to keep pace.

Technorati Tags: Amgen, Ilypsa, Alantos

Email Ed Vawter

Bookmark it with: | del.icio.us | Digg it | Furl | Simpy | Spurl | My Yahoo! |

I wanted to let readers know that the QDIS Blog now is mobile ready! If you want to look at the blog from a cell phone or other mobile device, then feel free. It will detect that you are accessing it on a mobile device and format it accordingly.

This was accomplished using a Wordpress plugin by Andy Moore. Here is the description:

Make your WordPress site accessible on a mobile phone with this plugin. Now your posts, pages, archives and comments can be viewed on a mobile device. Standards are supported, posts and comments can be submitted by phone and your WordPress mobile site is easily moneitized by AdMob.

http://www.andymoore.info/wordpress-mobile-plugin/

I hope you enjoy and let me know what you think. I have checked it out on my mobile phone and it looks good IMHO.
Technorati Tags: mobile ready

Email Ed Vawter

Bookmark it with: | del.icio.us | Digg it | Furl | Simpy | Spurl | My Yahoo! |